Suppr超能文献

库欣病的围手术期管理。

Peri-operative management of Cushing's disease.

机构信息

Division of Clinical and Molecular Endocrinology, University Hospitals of Cleveland, Case Medical Center, Louis Stokes Cleveland VA Medical Center and Case Western Reserve University, Cleveland, OH, USA.

出版信息

Rev Endocr Metab Disord. 2010 Jun;11(2):127-34. doi: 10.1007/s11154-010-9140-6.

Abstract

Management of patients with ACTH producing pituitary adenoma remains to be challenging. Removal of the pituitary adenoma through transsphenoidal surgery is the main stay of treatment. Complete resection of the adenoma is followed by the development of ACTH deficiency since the normal corticotrophs are suppressed by the pre-existing hypercortisolemia. The concern for ACTH deficiency has led many centers to advocate the use glucocorticoids before, during and after surgery. We provide evidence that such coverage with glucocorticoids is unnecessary until clinical or biochemical documentation of need is established. Given that patients are closely monitored, they are immediately treated with glucocorticoids once they exhibit any clinical and/or biochemical evidence of adrenal insufficiency. Defining remission in the immediate postoperative period has been rather difficult despite using different biochemical markers. Serum cortisol continues to be the best determinant of disease activity after surgical adenomectomy. However it needs to be interpreted with caution as a biochemical marker of remission in patients given glucocorticoids during and after surgery. Other biochemical markers are also used in the peri-operative period to determine the possibility of remission. These include the dexamethasone suppression test, CRH stimulation without dexamethasone, urinary free cortisol measurements, desmopressin stimulation test, the determination of salivary cortisol and / or plasma ACTH concentrations. Each test has its own advantages and limitations. The simplest and most informative approach is to measure serum cortisol levels repeatedly after surgery without the administration of exogenous glucocorticoids. Low serum cortisol levels (less than 2 μg/dL) in the peri-operative period are highly indicative of surgical success and a high likelihood for clinical remission. Higher serum cortisol levels require careful interpretation and further planning and discussions between the patient and the management team.

摘要

管理 ACTH 分泌性垂体腺瘤仍然具有挑战性。通过经蝶窦手术切除垂体腺瘤是治疗的主要方法。由于先前的高皮质醇血症抑制了正常的促皮质素细胞,因此腺瘤的完全切除后会导致 ACTH 缺乏。对 ACTH 缺乏的担忧导致许多中心主张在手术前、手术中和手术后使用糖皮质激素。我们提供的证据表明,在临床或生化证实需要之前,这种糖皮质激素的覆盖是不必要的。鉴于患者受到密切监测,一旦出现任何肾上腺皮质功能不全的临床和/或生化证据,他们会立即接受糖皮质激素治疗。尽管使用了不同的生化标志物,但在术后即刻确定缓解仍然相当困难。术后血清皮质醇仍然是手术切除腺瘤后疾病活动的最佳决定因素。然而,由于术后和术后给予糖皮质激素的患者,作为缓解的生化标志物,它需要谨慎解释。其他生化标志物也用于围手术期以确定缓解的可能性。这些包括地塞米松抑制试验、无地塞米松的 CRH 刺激、尿游离皮质醇测定、去氨加压素刺激试验、唾液皮质醇和/或血浆 ACTH 浓度的测定。每项检查都有其自身的优点和局限性。最简单和最具信息量的方法是在手术后不给予外源性糖皮质激素的情况下反复测量血清皮质醇水平。围手术期低血清皮质醇水平(<2μg/dL)高度提示手术成功和临床缓解的可能性高。较高的血清皮质醇水平需要仔细解释,并需要患者和管理团队之间进一步的计划和讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验